Statements (107)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:medical_devices
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:available_in |
gptkb:various_countries
|
| gptkbp:benefits |
reduces dependence on glaucoma medications
|
| gptkbp:clinical_trial |
conducted to assess efficacy
various phases conducted supports its effectiveness |
| gptkbp:competes_with |
other glaucoma treatments
|
| gptkbp:competitors |
faces competition from other MIGS devices
|
| gptkbp:complications |
minimal complications
|
| gptkbp:customer_satisfaction |
generally high
|
| gptkbp:designed_for |
minimally invasive procedures
|
| gptkbp:developed_by |
Glaukos Corporation
|
| gptkbp:eligibility |
determined by ophthalmologist
|
| gptkbp:events |
necessary after surgery
|
| gptkbp:feedback |
collected for improvement
|
| gptkbp:financial_support |
available for users.
|
| gptkbp:first_introduced |
gptkb:2012
|
| gptkbp:follow_up_visits |
recommended after surgery
|
| gptkbp:global_presence |
increasing globally
|
| gptkbp:has_approval_in |
gptkb:European_Union
|
| gptkbp:has_membership |
from general ophthalmologists
|
| https://www.w3.org/2000/01/rdf-schema#label |
i Stent
|
| gptkbp:implanted_during |
cataract surgery
|
| gptkbp:inserted_into |
anterior chamber of the eye
|
| gptkbp:invention |
patented technology
|
| gptkbp:is_associated_with |
lower risk of complications
fewer medications needed post-surgery |
| gptkbp:is_available_for |
outpatient procedures
|
| gptkbp:is_available_in |
various sizes
|
| gptkbp:is_compared_to |
traditional glaucoma surgeries
|
| gptkbp:is_considered_as |
a cost-effective solution
a patient-friendly option a minimally invasive option a breakthrough in glaucoma treatment a safe option for glaucoma surgery first FDA-approved MIGS device |
| gptkbp:is_designed_to |
reduce intraocular pressure
minimize tissue trauma |
| gptkbp:is_evaluated_by |
clinical studies
long-term effectiveness real-world studies |
| gptkbp:is_inserted_in |
anterior chamber of the eye
|
| gptkbp:is_linked_to |
improved patient outcomes
reduced need for traditional surgery |
| gptkbp:is_monitored_by |
important post-surgery
|
| gptkbp:is_part_of |
a broader category of MIGS devices
a comprehensive glaucoma treatment approach a treatment plan for glaucoma patients glaucoma management strategy i Stent family of products the evolution of glaucoma therapies the future of glaucoma surgery the future of minimally invasive surgery |
| gptkbp:is_promoted_by |
ophthalmic surgeons
|
| gptkbp:is_promoted_through |
medical conferences
|
| gptkbp:is_recognized_by |
ophthalmic societies
|
| gptkbp:is_recognized_for |
its innovative design
|
| gptkbp:is_recommended_for |
patients with mild to moderate glaucoma
|
| gptkbp:is_regarded_as |
a significant advancement in eye care
|
| gptkbp:is_supported_by |
gptkb:guidelines
clinical evidence patient testimonials |
| gptkbp:is_tested_for |
various clinical trials
|
| gptkbp:is_used_by |
ophthalmologists
|
| gptkbp:is_used_in |
combination with cataract surgery
various surgical settings |
| gptkbp:is_used_to |
lower eye pressure
|
| gptkbp:is_utilized_by |
eye care professionals
|
| gptkbp:is_visible_from |
improve quality of life
|
| gptkbp:long_term_results |
being studied
|
| gptkbp:made_of |
biocompatible materials
|
| gptkbp:manufacturer |
Glaukos Corporation
|
| gptkbp:marketed_as |
multiple countries
i Stent Trabecular Micro-Bypass Stent |
| gptkbp:material |
biocompatible material
|
| gptkbp:patient_education |
important for informed consent
|
| gptkbp:patient_population |
suitable for various age groups
|
| gptkbp:price |
considered cost-effective
|
| gptkbp:provides |
immediate reduction in eye pressure
|
| gptkbp:provides_guidance_on |
included in glaucoma treatment guidelines
|
| gptkbp:recruitment |
critical for success
|
| gptkbp:regulatory_compliance |
received in multiple regions
|
| gptkbp:research |
ongoing to evaluate long-term effects
|
| gptkbp:risk_factor |
like any surgical procedure
|
| gptkbp:specialties |
ab interno approach
includes monitoring intraocular pressure part of evolving glaucoma treatments requires specific instruments |
| gptkbp:success_rate |
high success rate in lowering pressure
|
| gptkbp:suitable_for |
advanced glaucoma cases
|
| gptkbp:surgeon_experience |
affects outcomes
|
| gptkbp:surgeon_training |
required for implantation
|
| gptkbp:surgical_duration |
short procedure
|
| gptkbp:surgical_guidelines |
established for best practices
|
| gptkbp:surgical_outcomes_data |
collected for analysis
|
| gptkbp:surgical_volume |
increasing in ophthalmology practices
|
| gptkbp:training_programs |
available for surgeons
|
| gptkbp:treatment |
improved vision
generally low evaluated in studies monitored in clinical settings |
| gptkbp:type |
micro-invasive glaucoma surgery (MIGS)
micro-invasive glaucoma surgery device |
| gptkbp:type_of_insurance |
varies by provider
|
| gptkbp:used_for |
treatment of glaucoma
|
| gptkbp:used_in |
cataract surgery
|